“Lansoprazole delayed-release capsules USP, 30 mg are white to pale yellow colored enteric coated pellets filled in size '1' hard gelatin capsules with opaque pink colored cap and opaque black colored body, imprinted 'RDY' on cap and '399' on body with white ink”
RDY 399 pill
Pill with imprint RDY 399 is black & pink, capsule, 19 mm and has been identified as Lansoprazole 30 mg. It is used for acid reflux (GERD), ulcers and stomach ulcers. It is supplied by Denton Pharma, Inc. Dba Northwind Pharmaceuticals.
Lansoprazole 30 mg
- Imprint
- RDY 399
- Strength
- 30 mg
- Used for
- Acid reflux (GERD), ulcers and stomach ulcers
- Color
- Black, Pink
- Shape
- Capsule / oblong
- Size
- 19 mm
- Score
- No score line
- Form
- Capsule, delayed release
- Manufacturer
- Denton Pharma, Inc. Dba Northwind Pharmaceuticals
- Drug class
- Acid reducer (proton pump inhibitor)
- NDC
- 70934-423, 55111-399, 70934-423-30, 55111-399-30, 55111-399-60, 55111-399-90, 55111-399-01, 55111-399-05, 55111-399-79, 68001-112, 68001-112-05, 68001-112-03, 68001-112-04, 71335-0917, 71335-0917-1, 71335-0917-2, 71335-0917-3, 71335-0917-4, 71335-0917-5, 71335-0917-6, 71335-0917-7, 71335-0917-8, 71335-0917-9, 63187-510, 63187-510-30, 63187-510-60, 63187-510-90, 50090-6830, 50090-6830-0, 60687-123, 60687-123-11, 60687-123-01, 0904-6662, 0904-6662-45, 67296-2270, 67296-2270-3
Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .
Report a mistake
What is Lansoprazole used for?
Lansoprazole is used for acid reflux (GERD), ulcers, stomach ulcers and H. pylori infection.
- Medicine type
- Acid reducer (proton pump inhibitor)
Official uses from the US prescribing label
Treatment of Active Duodenal Ulcer
Lansoprazole delayed-release orally disintegrating tablets are indicated in adults for short-term treatment (for four weeks) for healing and symptom relief of active duodenal ulcer.
Eradication of H. pylori to Reduce the Risk of Duodenal Ulcer Recurrence
Triple Therapy: Lansoprazole delayed-release orally disintegrating tablets /amoxicillin/clarithromycin
Lansoprazole delayed-release orally disintegrating tablets in combination with amoxicillin plus clarithromycin as triple therapy is indicated in adults for the treatment of patients with H. pylori infection and duodenal ulcer disease (active or one year history of a duodenal ulcer) to eradicate H. pylori. Eradication of H. pylori has been shown to reduce the risk of duodenal ulcer recurrence.
Please refer to the full prescribing information for amoxicillin and clarithromycin.
Dual Therapy: Lansoprazole delayed-release orally disintegrating tablets/amoxicillin
Lansoprazole delayed-release orally disintegrating tablets in combination with amoxicillin as dual therapy is indicated in adults for the treatment of patients with H. pylori infection and duodenal ulcer disease (active or one year history of a duodenal ulcer) who are either allergic or intolerant to clarithromycin or in whom resistance to clarithromycin is known or suspected (see the clarithromycin prescribing information, Microbiology section). Eradication of H. pylori has been shown to reduce the risk of duodenal ulcer recurrence.
Please refer to the full prescribing information for amoxicillin.
Maintenance of Healed Duodenal Ulcers
Lansoprazole delayed-release orally disintegrating tablets are indicated in adults to maintain healing of duodenal ulcers. Controlled studies do not extend beyond 12 months.
Treatment of Active Benign Gastric Ulcer
Lansoprazole delayed-release orally disintegrating tablets are indicated in adults for short-term treatment (up to eight weeks) for healing and symptom relief of active benign gastric ulcer.
Healing of NSAID-Associated Gastric Ulcer
Lansoprazole delayed-release orally disintegrating tablets are indicated in adults for the treatment of NSAID-associated gastric ulcer in patients who continue NSAID use. Controlled studies did not extend beyond eight weeks.
Risk Reduction of NSAID-Associated Gastric Ulcer
Lansoprazole delayed-release orally disintegrating tablets are indicated in adults for reducing the risk of NSAID-associated gastric ulcers in patients with a history of a documented gastric ulcer who require the use of an NSAID. Controlled studies did not extend beyond 12 weeks.
Treatment of Symptomatic Gastroesophageal Reflux Disease (GERD)
Lansoprazole delayed-release orally disintegrating tablets are indicated for short-term treatment in adults and pediatric patients 12 to 17 years of age (up to eight weeks) and pediatric patients one to 11 years of age (up to 12 weeks) for the treatment of heartburn and other symptoms associated with GERD.
Treatment of Erosive Esophagitis (EE)
Lansoprazole delayed-release orally disintegrating tablets are indicated for short-term treatment in adults and pediatric patients 12 to 17 years of age (up to eight weeks) and pediatric patients one to 11 years of age (up to 12 weeks) for healing and symptom relief of all grades of EE. For adults who do not heal with lansoprazole delayed-release orally disintegrating tablets for eight weeks (5 to 10%), it may be helpful to give an additional eight weeks of treatment. If there is a recurrence of erosive esophagitis an additional eight week course of lansoprazole delayed-release orally disintegrating tablets may be considered.
Maintenance of Healing of EE
Lansoprazole delayed-release orally disintegrating tablets are indicated in adults to maintain healing of EE. Controlled studies did not extend beyond 12 months.
Pathological Hypersecretory Conditions Including Zollinger-Ellison Syndrome (ZES)
Lansoprazole delayed-release orally disintegrating tablets are indicated in adults for the long-term treatment of pathological hypersecretory conditions, including Zollinger-Ellison syndrome.
From the FDA-approved label on DailyMed (published Sep 02, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your pill? Check every detail
- Your pill shows RDY 399. The parts can be split between the two sides, so turn the pill over and check both.
- It is black & pink, capsule, 19 mm.
- The score line, coating and any logo match the photo.
- It came from a pharmacy package that names the same drug.
Ingredients
Active: Lansoprazole
Inactive: Ammonia, Hydroxypropyl Cellulose (1600000 Wamw), Low-Substituted Hydroxypropyl Cellulose, Unspecified, Magnesium Carbonate, Methacrylic Acid - Ethyl Acrylate Copolymer (1:1) Type A, Polyethylene Glycol, Unspecified, Polysorbate 80, Propylene Glycol, Shellac, Starch, Corn, Sucrose, Raw Sugar, Titanium Dioxide, Talc, Gelatin, Unspecified, Ferrosoferric Oxide, Ferric Oxide Red, Ferric Oxide Yellow, Sodium Lauryl Sulfate
Also distributed by
Dr.reddy's Laboratories Ltd., Bluepoint Laboratories, Bryant Ranch Prepack, Proficient Rx LP, A-S Medication Solutions, American Health Packaging, Major Pharmaceuticals, Redpharm Drug
Pills that look similar but are different drugs
Same color and shape, different medicine. This is why the imprint matters.
- VANDA 85mg Tradipitant 85 mg Black & white, capsule, 19 mm Used for motion sickness
- ADAMAS 85 Three black bands Amantadine 68.5 mg Black & white, capsule, 18 mm Used for Parkinson's disease and flu
- MICRO 100 Nitrofurantoin 100 mg Black & yellow, capsule, 19 mm Used for urinary tract infections (UTIs) and escherichia coli infections
- 100 102 Nitrofurantoin/Macrocrystals) 75 mg / 25 mg Black & yellow, capsule, 20 mm
- 807 Lansoprazole DR 30 mg Black & white, capsule, 19 mm
- Macrobid 52427285 Nitrofurantoin/Macrocrystals 25 mg / 75 mg Black & yellow, capsule, 20 mm
Other Lansoprazole pills
-
RDY LAN
Lansoprazole 15 mg
Green & pink, capsule, 16 mm
Used for acid reflux (GERD) and ulcers
- TAP PREVACID 15 Lansoprazole 15 mg Green & pink, capsule, 16 mm Used for acid reflux (GERD) and ulcers
- TAP PREVACID 15 Lansoprazole 15 mg Green, capsule, 16 mm Used for acid reflux (GERD) and ulcers
- 15 Lansoprazole 15 mg White, round, 9 mm Used for acid reflux (GERD) and ulcers
- 93 7350 Lansoprazole 15 mg Blue & white, capsule, 16 mm Used for acid reflux (GERD) and ulcers
- W 669 Lansoprazole 15 mg Green & pink, capsule, 16 mm Used for acid reflux (GERD) and ulcers
- RDY 398 Lansoprazole 15 mg Green & pink, capsule, 16 mm Used for acid reflux (GERD) and ulcers
- H 166 Lansoprazole 15 mg Green & pink, capsule, 16 mm Used for acid reflux (GERD) and ulcers